Evidence map›Paper›PMID 41066417›Full record

ArticleThe FEBS journal2026

Binding of Bacillus subtilis dynamin-like protein DynA to the bacterial membrane is essential for effective phage defense.

Samia Shafqat, Urska Repnik, Marc Bramkamp

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samia ShafqatInstitute for General Microbiology, Kiel University, Germany.
Urska RepnikCentral Microscopy Facility, Kiel University, Germany.
Marc BramkampInstitute for General Microbiology, Kiel University, Germany.ORCID 0000-0002-7704-3266

Funding

Deutsche Forschungsgemeinschaft BR2915/13-1Higher Education Commission of Pakistan 57558560
6 · The paper itself

Abstract

Bacterial dynamin-like proteins are large GTPases that play crucial roles in membrane dynamics. Bacillus subtilis dynamin-like protein A (DynA), a two-headed bacterial dynamin-like protein, possesses membrane-binding and membrane-tethering functions in trans. The formation of large DynA clusters on bacterial membranes in response to pore-forming antibiotics and phages demonstrates its potential role in maintaining bacterial membrane integrity under various environmental stresses. In this study, we identified the membrane-binding site of B. subtilis DynA within the D1 subunit of the protein that includes positively charged lysine residues K360 and K367, as well as hydrophobic phenylalanine residues F363, F364, and F365. For experimental validation, recombinant proteins with amino acid substitutions in the lysine and phenylalanine residues were produced and used in liposome binding assays. Nonconservative substitutions led to a complete loss of DynA's membrane-binding capability. In vivo data showed strains with DynA variants lacking membrane-binding capability exhibit significantly increased susceptibility to phage infection compared with wild-type cells, further emphasizing the importance of DynA's membrane interaction in conferring phage resistance. Our findings bridge the gap between the structural characteristics of DynA and its functional implications in maintaining bacterial membrane integrity and mediating phage resistance.

Indexed as

Bacillus PhagesBacillus subtilisBacterial ProteinsBacteriophagesCell MembraneDynaminsAmino Acid SubstitutionBinding SitesLiposomesProtein BindingBacterial ProteinsDynaminsLiposomesBacillus subtilisbacterial innate immunityDynAdynamin‐like proteinsmembrane bindingphage

Identifiers

PMID41066417
PMCPMC12998192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.